ACADIA Pharmaceuticals, Inc. (ACAD)
21.61
-0.86
(-3.83%)
USD |
NASDAQ |
Feb 12, 16:00
21.93
+0.32
(+1.48%)
After-Hours: 04:21
ACADIA Pharmaceuticals Free Cash Flow : 98.97M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Marker Therapeutics, Inc. | -14.82M |
| Dynavax Technologies Corp. | 80.54M |
| Axsome Therapeutics, Inc. | -101.39M |
| Rhythm Pharmaceuticals, Inc. | -149.13M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 74.29M |
| Cash from Investing (Quarterly) | -79.35M |
| Cash from Financing (Quarterly) | 9.423M |
| Free Cash Flow Per Share (Quarterly) | 0.4331 |
| Free Cash Flow to Equity (Quarterly) | 75.38M |
| Free Cash Flow to Firm (Quarterly) | 73.90M |
| Free Cash Flow Yield | 2.72% |